Your browser doesn't support javascript.
loading
Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis.
Ahmed, Eman A; El-Derany, Marwa O; Anwar, Ali Mostafa; Saied, Essa M; Magdeldin, Sameh.
Afiliação
  • Ahmed EA; Proteomics and Metabolomics Research Program, Department of Basic Research, Children's Cancer Hospital 57357, Cairo 11441, Egypt.
  • El-Derany MO; Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Anwar AM; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
  • Saied EM; Proteomics and Metabolomics Research Program, Department of Basic Research, Children's Cancer Hospital 57357, Cairo 11441, Egypt.
  • Magdeldin S; Chemistry Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
Int J Mol Sci ; 24(1)2022 Dec 22.
Article em En | MEDLINE | ID: mdl-36613653

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article